Page last updated: 2024-08-18

cyclohexanol and Multiple Sclerosis

cyclohexanol has been researched along with Multiple Sclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, Z; Baker, D; Croxford, JL; Cuzner, ML; Giovannoni, G; Hankey, DJ; Jackson, SJ; Ledent, C; Petzold, A; Pocock, JM; Pryce, G; Thompson, AJ1
Baker, D; Pryce, G1

Other Studies

2 other study(ies) available for cyclohexanol and Multiple Sclerosis

ArticleYear
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.
    Brain : a journal of neurology, 2003, Volume: 126, Issue:Pt 10

    Topics: Animals; Aspartic Acid; Axons; Benzoxazines; Cannabinoids; Cyclohexanols; Dizocilpine Maleate; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Agonists; Gene Deletion; Humans; Mice; Mice, Transgenic; Monomeric GTP-Binding Proteins; Morpholines; Multiple Sclerosis; N-Methylaspartate; Naphthalenes; Nerve Degeneration; Nuclear Proteins; Receptors, Cannabinoid; Receptors, Drug; Receptors, N-Methyl-D-Aspartate; Retina; Saccharomyces cerevisiae Proteins; Spinal Cord; Uveitis

2003
Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.
    British journal of pharmacology, 2007, Volume: 150, Issue:4

    Topics: Animals; Benzoxazines; Body Temperature; Cross Reactions; Cyclohexanols; Encephalomyelitis, Autoimmune, Experimental; Mice; Mice, Knockout; Morpholines; Multiple Sclerosis; Muscle Spasticity; Naphthalenes; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2

2007